Bone health as a primary target in the pediatric age

European Review for Medical and Pharmacological Sciences

Volumn 13, Issue 2, 2009, Pages 117-128

  Caradonna, P ^a   Rigante, Donato ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Bone mineral density; Osteoporosis; Pediatrics

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; ACENOCOUMAROL; ALENDRONIC ACID; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CLODRONIC ACID; CORTICOSTEROID; CYCLOSPORIN; ETIDRONIC ACID; GLUCOCORTICOID; HEPARIN; IBANDRONIC ACID; METHOTREXATE; NERIDRONIC ACID; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PAMIDRONIC ACID; PARATHYROID HORMONE[1-34]; PHENYTOIN; PHOSPHATE; PROSTAGLANDIN; RISEDRONIC ACID; SELECTIVE ESTROGEN RECEPTOR MODULATOR; VITAMIN D; WARFARIN; ZOLEDRONIC ACID;

ACUTE KIDNEY FAILURE; ANOREXIA NERVOSA; ARTICLE; BONE DEMINERALIZATION; BONE DENSITOMETRY; BONE DENSITY; BONE DISEASE; BONE FRAGILITY; BONE MASS; BONE PAIN; CELIAC DISEASE; CELL ACTIVITY; CHILD HEALTH; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERITIS; ESOPHAGUS ULCER; FAMILIAL HYPOPHOSPHATEMIC RICKETS; FLU LIKE SYNDROME; FRACTURE; GASTROINTESTINAL IRRITATION; GROWTH RETARDATION; HEART ATRIUM FIBRILLATION; HEMATOLOGIC DISEASE; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOCALCEMIA; JAW OSTEONECROSIS; LEUKOPENIA; MORNING DOSAGE; NEOPLASTIC HYPERCALCEMIA; NEPHROTIC SYNDROME; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOGENESIS IMPERFECTA; OSTEOLYSIS; OSTEOMALACIA; OSTEOPENIA; OSTEOPOROSIS; PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY; PHYSICAL MEDICINE; QUANTITATIVE ULTRASOUND BONE DENSITOMETRY; RASH; RECOMMENDED DRUG DOSE; RICKETS; SIDE EFFECT; TOOTH DISEASE; ULTRAVIOLET RADIATION; VITAMIN SUPPLEMENTATION;

ADOLESCENT; AGE DETERMINATION BY SKELETON; AGE FACTORS; BONE DENSITY; BONE DISEASES, METABOLIC; CHILD; FEMALE; HUMANS; MALE; OSTEOPOROSIS; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 65649115081     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. KOBAYASHI T, KRONENBERG H. Minireview: Transcriptional regulation in development of bone. En docrinology 2005; 146: 1012-1017.
2. MANOLAGAS SC. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis Endocr Rev 2000; 21: 115-137.
3. CARRIÉ FÄSSLER AL, BONJOUR JP. Osteoporosis as a pediatric problem. Pediatr Clin North Am 1995; 42: 811-824.
4. MATKOVIC V, JEUC T, WARDLAW GM, IUCH JZ, GOEL PK, WRIGHT JK, ANDON MB, SMITH KT, HEANEY RP. Timing of peak bone mass in Caucasian females and its implication for prevention of osteoporosis. Inference from a cross-sectional model. J Clin Inves 1994; 93: 799-808.
5. HEANEY RP, ABRAMS S, DAWSON-HUGHES B, LOOKER A, MARCUS R, MATKOVIC V, WEAVER C. Peak bone mass Osteoporos Int 2000; 11: 985-1009.
6. DENT CE. Osteoporosis in childhood. Postgra Med J 1977; 53: 450-457.
7. SAGGESE G, BARONCELLI GI, BERTELLONI S. Osteoporosis in children and adolescents: Diagnosis, risk factors and prevention. J Ped Endocr Metab 2001; 14: 833-859.
8. JEE WS, YAO W. Overview: Animal models of osteopenia and osteoporosis. J Musculoskelet Neuronal Interact 2001; 1: 193-207.
9. WRITING GROUP FOR THE ISCD POSITION DEVELOPMENT CONFERENCE. Diagnosis of osteoporosis in men, premenopausal women and children. J Clin Densitom 2004; 7:17-26.
10. CASHMAN KD. Vitamin D in childhood and adolescence. Postgrad Med J 2007; 83: 230-235.
11. STAMP TC, BAKER LR. Recessive hypophosphataemic rickets and possible aetiology of the vitamin D-resistant' syndrome. Arch Dis Child 1976; 51: 360-365.
12. LANSKE B, RAZZAOUE MS. Vitamin D and aging: Old concepts and new insights. J Nutr Biochem 2007; 18: 771-777.
13. PRENTICE A. Vitamin D deficiency: A global perspective. Nutr Rev 2008; 66 (Suppl. 2): S153-S164.
14. CHEVALLEY T, BONJOUR JP, FERRARI S, RIZZOLI R. Influence of age at menarche on forearm bone microstructure in healthy young women. J Clin Endocrinol Metab 2008; 93: 2594-2601.
15. BACHRACH LK. Consensus and controversy regarding osteoporosis in the pediatric population. Endocr Pract 2007; 13: 513-520.
16. LEWIECKI EM, WATTS NB, MCCLUNG MR, PETAK SM, BACHRACH LK, SHEPHERD JA, DOWNS RW Jr, INTERNATIONAL SOCIETY FOR CLINICAL DENSITOMETRY. Official positions of the international society for clinical densitometry. J Clin Endocrinol Metab 2004; 89: 3651-3655.
17. WORLD HEALTH ORGANIZATION. Assesment of fracture risk and its application for screening for postmenopausal osteoporosis. WHO Technical Report Series 843. Geneva, WHO; 1994.
18. BIANCHI ML. Osteoporosis in children and adolescents. Bone 2007; 41: 486-495.
19. MARSHALL D, JOHNELL O, WEDEL H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996; 312: 1254-1259.
20. HAVILL LM, MAHANEY MC, L BINKLEY T, SPECKER BL. Effects of genes, sex, age, and activity on BMC, bone size, and areal and volumetric BMD. J Bone Miner Res 2007; 22: 737-746.
21. LEWIECKI EM, GORDON CM, BAIM S, BINKLEY N, BILEZIKIAN JP, KENDLER DL, HANS DB, SILVERMAN S, BISHOP NJ, LEONARD MB, BIANCHI ML, KALKWARF HJ, LANGMAN CB, PLOTKIN H, RAUCH F, ZEMEL BS. Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry. Osteoporos Int 2008; 19: 1369-1378.
22. CADDIDY JT. Osteopenia and osteoporosis in children. Clin Exp Rheumatol 1999; 17: 245-250.
23. LEWIECKI EM, GORDON CM, BAIM S, LEONARD MB, BISHOP NJ, BIANCHI ML, KALKWARF HJ, LANGMAN CB, PLOTKIN H, RAUCH F, ZEMEL BS, BINKLEY N, BILEZIKIAN JP, KENDLER DL, HANS DB, SILVERMAN S. International society for clinical densitometry 2007 adult and pediatric official positions. Bone 2008; 43:1115-1121.
24. LORENC RS. Idiopathic juvenile osteoporosis. Calcif Tissue Int 2002; 70: 395-397.
25. WAINWRIGHT H, BEIGHTON P. Osteogenesis imperfecta and holoprosencephaly. Clin Dysmorphol 2007; 16: 189-191.
26. RIGANTE D, CARADONNA P. Secondary skeletal involvement in Sanfilippo syndrome. QJM 2004; 97: 205-209.
27. MAÏMOUN L, FATTAL C, MICALLEF JP, PERUCHON E, RABISCHONG P. Bone loss in spinal cord-injured patients: From physiopathology to therapy. Spinal Cord 2006 44: 203-210.
28. SHETH RD. Metabolic concerns associated with antiepileptic medications. Neurology 2004; 63 S24-S29.
29. GOODMAN SB, JIRANEK W, PETROW E, YASKO AW. The effects of medications on bone. J Am Acad Orthop Surg 2007 15: 450-460.
30. HAMILTON C, SEIDNER DL. Metabolic bone diseas and parenteral nutrition. Curr Gastroenterol Re 2004; 6: 335-341.
31. SCHWARZ C, SULZRACHER I, OBERBAUER R. Diagnosis of renal osteodystrophy. Eur J Clin Invest 2006; 36 S113-S22.
32. HOLICK MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
33. MORA S, BARERA G, RICOTTI A, WEBER G, BIANCHI C, CHIUMELLO G. Reversal of low bone density with gluten-free diet in children and adolescents wit celiac disease. Am J Clin Nutr 1998; 67: 477-481
34. Biller BMK, Saxe V, Herzog DB, Rosenthal DI, Holzman S, Klibanski A. Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab 1989; 68: 548-554.
35. VAN DER EERDEN AW, DEN HEUER M, OYEN WJ, HEMUS AR. Cushing's syndrome and bone mineral density: Lowest Z scores in young patients. Neth Med 2007; 65: 137-141.
36. BIANCHI ML. Glucorticoids and bone: Some general remarks and some special observations in pediatric patients. Calcif Tissue Int 2002; 70: 384-390
37. OOLF AD. An update on glucocorticoid-induced osteoporosis. Curr Opin Rheumatol 2007; 19: 370-375.
38. WEISMAN MH. Corticosteroids in the treatment of rheumatologic diseases. Curr Opin Rheumatol 1995; 7: 183-190.
39. BISHOP N, BRAILLON P, BURNHAM J, CIMAZ R, DAVIES J FEWTRELL M, HOGLER W, KENNEDY K, MÄKITIE O, MUGHAL Z, SHAW N, VOGIATZI M, WARD K, BIANCHI ML. Dual-energy X-ray aborptiometry assessment in children and adolescents with diseases that may affect the skeleton: The 2007 ISCD Pediatric Official Positions. J Clin Densitorn 2008; 11: 29-42.
40. SEEMAN E. Structural basis of growth-related gain and age-related loss of bone strength. Rheumatology (Oxford) 2008; 47 Suppl. 4: 2-8.
41. HAMADANI M, CHAUDHRAY AL. McCune-Albright syndrome. Med J Aust 2006; 185: 597.
42. GUREVITCH O, SLAVIN S. The hematological etiology of osteoporosis. Med Hypotheses 2006; 67:729-735.
43. EL MAGHRAOUI A, ROUX C. DXA scanning in clinical practice. QJM 2008; 101: 605-617.
44. VAN DER SLUIS IM, DE RIDDER MA, BOOT AM, KRENNING EP, DE MUINCK KEIZER-SCHRAMA SM. Reference data for bone density and body composition measured with dual energy X ray absorptiometry in white children and young adults. Arch Dis Child 2002; 87: 341-347.
45. KALKWARF HJ, ZEMEL BS, GILSANZ V, LAPPE JM, HORUCK M, OBERFIELD S, MAHBOUBI S, FAN B, FREDERICK MM, WINER K, SHEPHERD JA. The bone mineral density in childhood study: Bone mineral content and density according to age, sex and race. J Clin Endocrinol Metab 2007; 92: 2087-2099.
46. SALA A, WEBBER CE, MORRISON J, BEAUMONT LF, BARR RD. Whole-body bone mineral content, lean body mass, and fat mass measured by dual-energy X-ray absorptiometry in a population of normal Canadian children and adolescents. Can Assoc Radiol J 2007; 58: 46-52.
47. XU H, CHEN JX, GONG J, ZHANG TM, WU OL, YUAN ZM, WANG JP. Normal reference for bone density in healthy Chinese children. J Clin Densitom 2007; 10: 266-275.
48. SHU SG. Bone mineral density and correlation factor analysis in normal Taiwanese children. Acta Paediatr Taiwan 2007; 25: 423-430.
49. CARTER DR, BOUXSEIN ML, MARCUS R. New approaches for interpreting projected bone densitometry data. J Bone Miner Res 1992; 7: 137-145.
50. KATE SC, TONG X, HENDRICK JM, KARIMOVA EJ, SRIVASTAVA DK, TYLAVSKY FA, SNIDER TL, CARBONE LD. QCT versus DXA in 320 survivors of childhood cancer: Association of BMD with fracture history. Pediatr Blood Cancer 2006; 47: 936-943.
51. BARONCELLI GI, FEDERICO G, BERTELLONI S, DE TERLIZZI F, CADOSSI R, SAGGESE G. Bone quality assessment by quantitative ultrasound of proximal phalanxes of the hand in healthy subjects aged 3-21 years. Pediatr Res 2001; 49: 713-718.
52. AMERICAN COLLEGE OF RHEUMATOLOGY TASK FORCE ON OSTEOPOROSI GUIDELINES . Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 1996; 39: 1791-1801.
53. GIUSTINA A, MAZZIOTTI G, CANALIS E. Growth hormone, insulin-like growth factors and the skeleton. Endocr Rev 2008; 29: 535-559.
54. JOHNSTON CC JR, MILLER JZ, SLEMENDA CW, REISTER TK, HUI S, CHRISTIAN JC, PEACOCK M. Calcium supplementation and increases in bone mineral density in children. N Engl J Med 1992; 327: 82-87.
55. CHEVALLEY T, BONJOUR JP, FERRARI S, HANS D, RIZZOLI R. Skeletal site selectivity in the effects of calcium supplementation on areal bone mineral density gain: A randomized, double-blind, placebo-controlled trial in prepubertal boys. J Clin Endocrinol Metab 2005; 90: 3342-3349.
56. BONJOUR JP, CARRIE AL, FERRARI S, CLAVIEN H, SLOSMAN D, THEINTZ G, RIZZOLI R. Calcium-enriched food and bone mass growth in prepubertal girls: A randomized, double-blind, placebo-controlled trial. J Clin Invest 1997; 99: 1287-1294.
57. BISCHOFF-FERRARI HA, REES JR, GRAU MV, BARRY E, GUI J, BARON JA. Effect of calcium supplementation on fracture risk: A double-blind randomized controlled trial. Am J Clin Nutr 2008; 87: 1945-1951.
58. SHOEMAKER LR. Expanding role of bisphosphonate therapy in children. J Pediatr 1999; 134: 264-267.
59. NAKAYAMADA S, OKADA Y, SAITO K, TANAKA Y. Etidronate prevents high dose glucocorticoid induced bone loss in premenopausal individuals with systemic autoimmune diseases. J Rheumatol 2004; 31: 163-166.
60. ISRAELI RS, ROSENBERG SJ, SALTZSTEIN DR, GOTTESMAN JE, GOLDSTEIN HR, HULL GW, TRAN DN, WARSI GM, LACERNA LV. The effect of zoledronic acid on bone mineral density in patients undergoing androgen deprivation therapy. Clin Genitourin cancer 2007; 5: 271-277.
61. BIANCHI ML, CIMAZ R, BARDARE M, ZULLAN F, LEPORE L, BONCOMPAGNI A, GALBIATI E, CORONA F, LUISETTO G, GIUNTINI D, PICCO P, BRANDI ML, FALCINI F. Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children. Arthritis Rheum 2000; 43: 1960-1966.
62. GATTI D, ANTONIAZZI F, PRIZZI R, BRAGA V, ROSSINI M, TATÒ L, VIAPIANA O, ADAMI S. Intravenous neridronate in children with osteogenesis imperfecta: A randomized controlled study. J Bone Miner Res 2005; 20: 758-763.
63. PATLAS N, GOLOMB G, YAFFE P, PINTO T, BREUER E, ORNOY A. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology 1999; 60: 68-73.
64. BIANCHI ML. Diagnosis and treatment of bone fragility in childhood. IBMS BoneKEy 2008; 5: 323-335.